Danaher Co. (NYSE:DHR) Shares Purchased by Northstar Asset Management Inc.

Northstar Asset Management Inc. grew its position in shares of Danaher Co. (NYSE:DHR) by 0.6% during the 3rd quarter, according to the company in its most recent filing with the SEC. The firm owned 34,654 shares of the conglomerate’s stock after purchasing an additional 190 shares during the quarter. Danaher accounts for 2.4% of Northstar Asset Management Inc.’s portfolio, making the stock its 18th largest position. Northstar Asset Management Inc.’s holdings in Danaher were worth $9,635,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently modified their holdings of the company. CarsonAllaria Wealth Management Ltd. bought a new position in shares of Danaher during the 2nd quarter valued at about $25,000. nVerses Capital LLC acquired a new position in Danaher in the second quarter worth approximately $25,000. MFA Wealth Advisors LLC bought a new position in shares of Danaher in the second quarter valued at $51,000. Financial Connections Group Inc. acquired a new stake in shares of Danaher during the 2nd quarter valued at $51,000. Finally, Western Pacific Wealth Management LP bought a new stake in shares of Danaher during the 1st quarter worth $55,000. Institutional investors own 79.05% of the company’s stock.

Insider Buying and Selling at Danaher

In other Danaher news, SVP Georgeann Couchara sold 952 shares of the business’s stock in a transaction that occurred on Monday, August 26th. The stock was sold at an average price of $268.37, for a total transaction of $255,488.24. Following the transaction, the senior vice president now owns 4,212 shares of the company’s stock, valued at $1,130,374.44. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Company insiders own 10.90% of the company’s stock.

Danaher Stock Up 1.2 %

NYSE:DHR opened at $250.16 on Wednesday. The firm has a market capitalization of $180.68 billion, a P/E ratio of 47.74, a P/E/G ratio of 4.55 and a beta of 0.85. The stock’s fifty day simple moving average is $266.16 and its 200-day simple moving average is $260.84. The company has a quick ratio of 1.01, a current ratio of 1.37 and a debt-to-equity ratio of 0.32. Danaher Co. has a 12-month low of $192.35 and a 12-month high of $281.70.

Danaher (NYSE:DHR) last issued its quarterly earnings data on Tuesday, October 22nd. The conglomerate reported $1.71 EPS for the quarter, topping the consensus estimate of $1.57 by $0.14. Danaher had a return on equity of 10.62% and a net margin of 16.39%. The business had revenue of $5.80 billion for the quarter, compared to the consensus estimate of $5.59 billion. During the same quarter last year, the business posted $2.02 EPS. The firm’s revenue was up 3.1% compared to the same quarter last year. Equities research analysts expect that Danaher Co. will post 7.51 earnings per share for the current year.

Danaher Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, October 25th. Stockholders of record on Friday, September 27th were given a $0.27 dividend. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.43%. The ex-dividend date of this dividend was Friday, September 27th. Danaher’s dividend payout ratio is presently 20.61%.

Analyst Upgrades and Downgrades

A number of equities analysts recently weighed in on DHR shares. Stifel Nicolaus increased their price target on Danaher from $250.00 to $265.00 and gave the company a “hold” rating in a research report on Wednesday, October 23rd. Stephens restated an “overweight” rating and set a $315.00 price target on shares of Danaher in a report on Wednesday, October 23rd. Royal Bank of Canada decreased their price objective on shares of Danaher from $333.00 to $311.00 and set an “outperform” rating for the company in a research note on Wednesday, October 23rd. Wolfe Research raised shares of Danaher from a “peer perform” rating to an “outperform” rating and set a $285.00 target price on the stock in a research note on Thursday, October 31st. Finally, Wells Fargo & Company initiated coverage on Danaher in a research note on Tuesday, August 27th. They set an “equal weight” rating and a $280.00 target price on the stock. Six equities research analysts have rated the stock with a hold rating and fourteen have given a buy rating to the stock. Based on data from MarketBeat, Danaher currently has an average rating of “Moderate Buy” and an average target price of $287.16.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.